Reaction
Erosive Oesophagitis reporting signals
As of the last recalculation, Erosive Oesophagitis appears in 1,680 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is MESNA INJECTION (PRR 19.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Mesna Injection | 13 | 19.6 | 19.7 |
| Mesna | 13 | 19.3 | 19.3 |
| Olmesartan Medoxomil | 49 | 17.4 | 17.4 |
| Esomeprazole Magnesium | 233 | 14.2 | 14.2 |
| Sucralfate | 26 | 13.6 | 13.7 |
| Sucralfate Oral | 11 | 9.6 | 9.6 |
| Sucralfate Oral Suspension | 11 | 9.6 | 9.6 |
| Abacavir Sulfate | 6 | 7.7 | 7.7 |
| Ifosfamide | 12 | 7.0 | 7.0 |
| Aprepitant | 10 | 6.7 | 6.7 |
| Gefitinib | 4 | 5.5 | 5.5 |
| Sevelamer Carbonate | 5 | 5.4 | 5.4 |
| Crizotinib | 5 | 4.9 | 4.9 |
| Dabigatran Etexilate Mesylate | 25 | 4.3 | 4.3 |
| Dabigatran Etexilate | 26 | 4.2 | 4.2 |